Market Tracker

10/30 10:00pm ET

Neogenomics Inc (NASDAQ:NEO)

5.48
Data as of 3:59pm ET
 +0.15 / +2.81%
Today’s Change
2.95
Today|||52-Week Range
6.10
+51.38%
Year-to-Date

Today’s Trading

Previous close5.33
Today’s open5.49
Day’s range5.29 - 5.64
Volume847,130
Average volume (3 months)318,657
Market cap$309.4M
Dividend yield--
Data as of 3:59pm ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)+2,976.92%
Earnings growth (this year)-91.67%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+11.02%
P/E ratio137.0
Price/Sales2.63
Price/Book12.06

Competitors

 Today’s
change
Today’s
% change
CTICCTi Biopharma Corp-0.04-1.65%
RDNTRadNet Inc+0.02+0.22%
GNMKGenMark Diagnostics ...+0.29+2.90%
NBSNeoStem Inc-0.03-0.58%
Data as of 3:59pm ET, 10/30/2014

Financials

Last reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$66.5M
Annual profit (last year)$2.0M
Net profit margin3.06%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. VanOort
Chief Operating Officer
Robert J. Shovlin
Corporate headquarters
Fort Myers, Florida

Forecasts